Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP)
$0.60
+0.0076 ( +1.27% ) 555.1K
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.
Market Data
Open
$0.60
Previous close
$0.60
Volume
555.1K
Market cap
$10.54M
Day range
$0.59 - $0.61
52 week range
$0.58 - $58.88
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 70 | Jul 16, 2024 |
8-k | 8K-related | 25 | Jul 10, 2024 |
8-k | 8K-related | 14 | Jul 08, 2024 |
8-k | 8K-related | 13 | Jul 01, 2024 |
8-k | 8K-related | 25 | Jun 28, 2024 |
8-k | 8K-related | 14 | Jun 26, 2024 |
8-k | 8K-related | 14 | Jun 20, 2024 |
8-k/a | 8K-related | 16 | Jun 14, 2024 |
8-k | 8K-related | 24 | Jun 13, 2024 |
8-k | 8K-related | 181 | Jun 10, 2024 |